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Inﬂammatory processes are known to be involved at least in the early phase of complex regional pain syndrome type 1 (CRPS1).
Blister ﬂuid obtained from the involved extremities displayed increased amounts of proinﬂammatory cytokines IL-6 and TNFα
compared with the noninvolved extremities. The aim of this paper is to investigate the involvement of mediators by measurement
of several other cytokines using new detection techniques that enable multiple cytokine measurement in small samples. The use
of a multiplex-25 bead array cytokine assay and Luminex technology enabled simultaneous measurement of representative (1)
proinﬂammatory cytokines such as GM-CSF, IL-1β,I L - 1 R A ,I L - 6 ,I L - 8 ,a n dT N F - α; (2) Th1/Th2 distinguishing cytokines IFN-γ,
IL-2, IL-2R, IL-4, IL-5, and IL-10; (3) nonspeciﬁc acting cytokines IFN-α, IL-7, IL-12p40/p70, IL-13, IL-15, and IL-17; and (4)
chemokines eotaxin, IP-10, MCP-1, MIP-1α, MIP-1β, MIG, and RANTES. Although minimal detection levels are signiﬁcantly
higher in the bead array system than those in common ELISA assays, in blister ﬂuid, IL-1RA, IL-6, IL-8, TNF-α, IL-12p40/p70,
MCP-1, and MIP-1β were detectable and increased in CRPS1 aﬀected extremities. Levels of IL-6 and TNF-α simultaneously mea-
suredbyELISA(SanquinCompactkit)andbymultiplex-25beadarrayassay(Biosource)werehighlycorrelated(r = 0.85,P<. 001
for IL-6 and r = 0.88, P<. 001 for TNF-α). Furthermore, IP-10 and eotaxin were detectable but diminished in CRPS1, whereas
detectable amounts of IL-10 were similar in involved and noninvolved extremities. Multiplex bead array assays are useful systems
toestablishtheinvolvementofcytokinesininﬂammatoryprocessesbymeasurementsinblisterﬂuidsofCRPS1.Tenrepresentative
cytokines were detectable. However, detection levels and amounts measured are at least 3 times higher in the multiplex-25 array
assay than in the ELISA assays used simultaneously for the measurement of cytokines.
Copyright © 2006 Claudia Heijmans-Antonissen et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
INTRODUCTION
Complex regional pain syndrome type 1 (CRPS1), also
known as reﬂex sympathetic dystrophy (RSD), is a debili-
tating painful disease in an extremity that is characterized
by signs of allodynia and hyperalgesia, as well as vasomo-
tor, sudomotor, and motor trophic signs and symptoms. In
general the disease persists in one extremity [1, 2]. The di-
agnosis of CRPS1 is mainly based on clinical observation
[3, 4], for which international research criteria have been
determined [5]. Although some patients develop CRPS1 af-
ter an inciting event (trauma or surgery in the hand, foot,
or knee), the origin of this invalidating disease remains un-
known. Subgroups of CRPS1 patients are described in whom
either vasomotor signs, neuropathic pain, or all signs of in-
ﬂammation are prominent factors [6]. Studies on the under-
lying mechanisms of this disease have ranged from the ef-
fects of physiotherapy to pharmaceutical intervention and
from biological active mediators to genetic mapping. Dur-
ing the initial stage of the disease most symptoms, such as
oedema, redness, loss of function, and temperature changes
[7], suggest a local inﬂammatory process [8]. Therefore we
subsequently investigated the involvement of inﬂammatory
mediators during the initial stage of this disease and showed
that the cytokines interleukin-6 (IL-6) and tumour necro-
sis factor α (TNF-α) were signiﬁcantly increased in the af-
fected hand or foot [9], which was conﬁrmed by other mark-
ers of inﬂammation [10]. Most treatments of CRPS1 are not2 Mediators of Inﬂammation
evidencebased.Thepatient-dependentchoiceofeitherphys-
ical therapy, pharmaceutical intervention, or unconventional
alternative medicine is still a matter of debate [8, 11]. Tar-
geted treatment with anti-TNF (Inﬂiximab) seems, however,
to be successful in patients with conﬁrmed signs of inﬂam-
mation [12].
In all our recent studies, skin blister ﬂuids showed ele-
vated amounts of IL-6 and TNF-α as a measure of local in-
ﬂammation intensity. Due to the limited amount of ﬂuid,
however, in the same sample we were only able to measure
2o r3d i ﬀerent mediators separately. Therefore the present
study aimed to conﬁrm the involvement of inﬂammatory
processes underlying CRPS1 by measuring a large variety of
cytokines simultaneously in the same small blister ﬂuid sam-
ple.
Until now commercially available enzyme-linked im-
munosorbent assay (ELISA) kits are used to measure levels
of cytokines in biological samples. Most of these kits require
atwo-folddilutedsamplevolumeof100μL.Therefore,toex-
amine a number of diﬀerent classes of cytokines, volumes of
more than a few hundred μL should be available, otherwise
dilutions need to be made. However, this process of dilution
could result in values that are below the detectable standard.
The simultaneous measurement of a number of cytokines in
a single sample using a new developed microbead-based ﬂow
cytometrysystem(Luminex)enablestodetectofcytokinesin
small volume samples of human biological material [13].
Successful measurement of six Th1/Th2 cell distinguish-
ing cytokines (interferon-γ (IFN-γ), TNF-α, IL-2, IL-4, IL-5,
and IL-10) has been reported in a single sample of human
tears obtained from allergic patients [14, 15], and in plasma
fromchildrenwithneonatalsepsis;inthesenewborninfants,
in the same samples the contribution of inﬂammatory cy-
tokines (IL-1β, IL-6, IL-8, IL-10, IL-12, and TNF-α) was also
evaluated [16]. This so-called inﬂammation panel was also
used for the simultaneous measurement of cytokines in tra-
cheal aspirates after mechanical ventilation [17].
Here we report on the simultaneous detection of 25 cy-
tokines in blister ﬂuids obtained from both the involved and
the noninvolved (contralateral) extremities of CRPS1 pa-
tients. This is the ﬁrst study in which such a large number of
inﬂammatory cytokines, Th1/Th2 distinguishing cytokines,
and chemokines have been investigated in human skin blis-
ter ﬂuids.
METHODS AND MATERIALS
Patientsandblisterﬂuids
Forthisstudy22patients(4males,18females;meanage52±
8.2 (SD) years) were selected, with a mean duration of the
diseaseof2.75±1.25(SD)years,allbeingintheintermediate
phase.DuringCRPS1weingeneraldistinguishfourdiﬀerent
diseasephases.StageIisdeﬁnedasthewarmorhypertrophic
phase,stageIIisdeﬁnedastheintermediatephase,stageIIIis
deﬁned as the cold or early chronic phase, and at last in stage
IV the deﬁnite chronic phase corresponds to atrophic signs,
dystonia, and per deﬁnition stabilization of the disease or, in
rare instances, to healing [8–12, 18].
All 22 patients were characterized using the impairment
sumscore(ISS,accordingtoOerlemansetal[7]).Atthetime
of the study this was 38 ± 16.6 (SD) on a scale of 0–100, in-
dicating a medium disease activity. This score was calculated
based on diﬀerences in skin surface temperature, volume of
oedema, quantity of pain (visual analogue scale), intensity of
pain (McGill Pain Questionnaire), and motor function (as
active range of motion).
Blisters were induced by means of a suction method
[9, 10]. A 3-hole (5mm diameter per hole) skin suction
chamber was positioned on the skin of the upper extremity,
on the dorsal side of the involved hand and the ﬂexor side of
the noninvolved forearm.
A vacuum of 300mm Hg negative pressure was applied
with an Atmoforte 350A aspirator pump (ATMOS Mediz-
inTechnik, Lenzkirch, Germany), which was reduced after
15 minutes to 250mm Hg and again, 15 minutes later, re-
duced to 200mm Hg. This negative pressure was maintained
until blisters containing suﬃcient ﬂuid had been developed,
but not longer than 2.5 hours. The contents of the blisters
were punctured and pooled from each side into a 1.5mL
Eppendorf conical polypropylene tube and centrifuged for
5 minutes at 1600xg. The mean recovery of supernatants
from control blisters was 173 ± 21 (± SEM) μL ﬂuid, and
168 ± 17μL blister ﬂuid from the CRPS1 side. All samples
were stored in 1 mL conical polypropylene tubes at −80◦C
until analysis [9].
In these blister ﬂuid samples IL-6 and TNF-α were an-
alyzed separately by ELISA and a set of 25 cytokines were
analyzed simultaneously using the Luminex system and the
multiplex-25 array assay from Biosource.
Enzyme-linkedimmunosorbentassays
Blister samples were diluted 4-fold in appropriate calibra-
tor diluent assay buﬀer for the direct measurement of cy-
tokines. Cytokine assays were performed following the man-
ufacturers protocol (Pelikine human ELISA compact kits for
IL-6 (M1906) and TNF-α (M1920), Sanquin, Amsterdam,
The Netherlands). The standard curve ranges and mean cal-
culated zero signal plus 3 SD for IL-6 were 0–450pg/mL
and 0.2pg/mL, respectively; and for TNF-α 0–1000pg/mL
and 1pg/mL, respectively. The requested solutions were pro-
vided with the ELISA compact kits and additional toolk-
its (Pelikine-Tool set (M1980), Sanquin, Amsterdam, The
Netherlands).
In brief, the ELISA procedure (performed at room tem-
perature) was as follows: The wells of a 96-well plate were
precoated overnight with 100μL of coating antibody, diluted
1 : 100 with coating buﬀer (0.1M carbonate/bicarbonate).
Thereafter the wells were washed 5 times with 400μLo f
phosphate buﬀered saline (PBS) containing 0.005% Tween
and then blocked with 200μL of blocking buﬀer (1 : 20
diluted in PBS) for 1 hour on a shaker. After washing the
plate ﬁve times with washing buﬀer, 100μL of unknown blis-
ter ﬂuid samples (diluted 1 : 4 in assay dilution buﬀer) or
standards were pipetted into the wells. The plate was incu-
bated for 1 hour on a shaker. After washing the plate ﬁveClaudia Heijmans-Antonissen et al 3
times with washing buﬀer, 100μL of biotinylated antibody
(diluted1 : 100inassaydilutionbuﬀer)waspipettedintothe
wells and incubated 1 hour on the shaker. After washing the
plate, the wells were incubated 30 minutes on a shaker with
100μL of streptavidin-HRP conjugate (diluted 1 : 10,000 in
assay dilution buﬀer). Thereafter the plate was washed for
the last time with washing buﬀer and incubated with 100μL
of tetramethylbenzidine substrate solution. The reaction was
stopped after 30 minutes with 100μLo fs t o ps o l u t i o n( 1 .8
M2SO4). The absorbance per well was measured at 450nm
with a Medgenix ELISA reader. Sample concentrations were
calculated using the appropriate standard calibration lines
and the Softmax software of the reader.
Multiplex-25beadarrayassay
The human cytokine multiplex-25 bead array assay kit for
Luminex was purchased from Biosource (Nivelles, Belgium).
This kit comprises all components necessary for the whole
assay procedure to be fulﬁlled within approximately 5 hours
hands-on time.
The following cytokines could be measured:
(i) inﬂammatory panel:G M - C S F( g r a n u l o c y t e - m a c r o -
phage colony-stimulating factor), IL-1β, IL-1RA (in-
terleukin-1 receptor antagonist), IL-6, IL-8, TNF-α;
(ii) Th1/Th2 panel:I F N - γ, IL-2, IL-2R, IL-4, IL-5, IL-10;
(iii) cytokineIIpanel:IFN-α,IL-7,IL-12p40/p70,IL-13,IL-
15, IL-17;
(iv) chemokinepanel:eotaxin,IP-10(interferon-γ inducing
protein, 10kDa), MCP-1 (monocyte chemotactic pro-
tein), MIP-1α (macrophage inﬂammatory protein),
MIP-1β, MIG (monokine induced by γ-interferon),
RANTES (regulated upon activation normal T cell ex-
pressed and secreted).
Standard curves for each cytokine (in duplicate) were gener-
ated by using the reference cytokine concentrations supplied
in this kit. Blister samples were diluted 4-fold in appropri-
ate assay diluent. The assay was performed in a 96-well ﬁlter
plate, using all the assay components provided in the kit. All
incubation steps were performed at room temperature and
in the dark to protect the beads from light.
In brief, the following procedure was performed: ﬁrstly,
theﬁlterplatewasprewettedwith200μLofworkingwashing
solution and then this solution was aspirated from the wells
using a vacuum manifold. The beads (25μL) were pipet-
ted into each well and thereafter the ﬁlter plate wells were
washed two times with washing buﬀer using the vacuum
manifold. Incubation buﬀer (50μL) and 1 : 4 diluted blis-
ter ﬂuid samples or standards (50μL) were pipetted into the
wells and incubated for 2 hours with the beads. Thereafter
the wells were washed using the vacuum manifold and de-
tector antibody conjugated to biotin (diluted 1 : 10 with bi-
otin diluent) was added. After incubation for 1 hour, beads
were washed again followed by an incubation of 30 min-
utes with streptavidin conjugated to the ﬂuorescent protein,
R-phycoerythrin (Streptavidin-RPE, diluted 1 : 10). After
washingtoremovetheunboundStreptavidin-RPE,thebeads
(minimum of 50 beads per cytokine) were analyzed in the
Luminex 100 instrument (Applied Cytometry Systems, Din-
nington,UK),whichmonitoredthespectralpropertiesofthe
beads while simultaneously measuring the amount of ﬂuo-
rescence associated with R-phycoerythrin. Raw data (mean
ﬂuorescence intensity, MFI) were analyzed using StarStation
software (Applied Cytometric Systems, Dinnington, UK).
Statisticalanalysis
All cytokines showed a skewed distribution. Comparison of
paired samples (CRPS1 versus noninvolved extremity) was
performed with the paired t test after logarithmic transfor-
mation of the data obtained from measurements in blister
ﬂuids. In case of values below the detection limit, the out-
come was set at the detection limit and the paired sam-
ple t test with adjustment for these left-censored values was
performed using STATA software (CNREG procedure). The
same method was used to assess the assumed linear relation
shown in Figure 1. Correlation coeﬃcients were determined
by the Spearman’s test for untransformed data.
RESULTS
To our knowledge we are the only clinical investigators re-
porting on cytokine levels in blister ﬂuids obtained from
CRPS1 patients [9, 10, 19]. Therefore we searched for data
obtained from artiﬁcial blisters in immunological skin dis-
e a s e si no r d e rt oc o m p a r ed e t e c t i o nr a n g e s( Table 1).
ELISA
Both IL-6 and TNF-α were measured in blister ﬂuid samples
of 22 CRPS1 patients, obtained from both the involved and
the noninvolved extremity. Standards were measured in du-
plicate for 8 data points including a zero standard. Standard
curves were plotted through a four-parameter logistic curve
ﬁtting. R-squared values were 0.999 and 1.00, respectively.
Calculated levels are presented in Table 2. Because cytokines
displayed a not normally distributed set of data, the median
and the ranges are presented. Interleukin-6 and TNF-α were
signiﬁcantlyincreasedattheCRPS1side(pairedsampletest).
Multiplex
Twenty-ﬁvecytokinesweremeasuredinthesameblisterﬂuid
samplesofthe22CRPS1patientsasindicatedintheprevious
section “ELISA.” Cytokine-speciﬁc single beads (25 diﬀerent
bead populations) were identiﬁed through sequential gating
on doublet discriminator signal and intrinsic bead dye (red
versus infrared) excluding bead aggregates and debris. The
amount of cytokine was measured as mean ﬂuorescence in-
tensity (MFI) of the Streptavidin-RPE signal on the outside
ofthebeadsfromaminimumof50beadspercytokine.Stan-
dards were measured in duplicate for 9 data points including
a zero standard.
Standard curves were plotted through a four- or ﬁve-
parameter logistic curve ﬁtting. All R-squared values were
between 0.99 and 1.00, except for IL-7 (0.968).4 Mediators of Inﬂammation
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Figure 1: Regression curves of 44 samples of blister ﬂuid obtained
from 22 CRPS1 patients, both from the involved and the nonin-
volved extremity. Values calculated in pg/mL were plotted on log-
arithmic scales. Regression lines were calculated taking into ac-
count the left-censored values due to detection limits as described
in the statistical methods. Dotted lines indicate detection levels of
the multiplex-25 cytokine assay. (a) Regression curve of IL-6 data
from the multiplex-25 cytokine assay and the ELISA kit (r = 0.85,
P<. 001), (b) regression curve of TNF-α data from the multiplex-
25 cytokine assay and the ELISA kit (r = 0.88, P<. 001).
In blister ﬂuid from the “inﬂammatory panel”I L - 1 R A ,
IL-6, IL-8, and TNF-α were detectable, from the “cytokine
II panel” IL-12p40 was detectable and from the “chemokine
panel” MCP-1 and MIP-1β were detectable and all were in-
creased in CRPS1 aﬀected extremities.
Furthermore, from the “chemokine panel” IP-10 and eo-
taxin were detectable and diminished in CRPS1, whereas
from the “Th1/Th2 panel” detectable amounts of IL-10 were
similar in both extremities (Table 3).
Statisticalconsiderations
An analysis by using nonparametric statistics (Wilcoxon’s
signed rank test), with outcomes set at the lower limit of de-
tections in case of values below this limit, resulted in similar
P-values for all parameters. We did not adjust for multiple
comparison tests because our study had an exploratory char-
acter.
Comparisonofthetwomethods
Levels of IL-6 and TNF-α measured by ELISA and by the
multiplex-25 bead array assay were highly correlated (r =
0.85, P<. 001 for IL-6, Figure 1(a),a n dr = 0.88, P<. 001
for TNF-α, Figure 1(b)).
In the multiplex-25 bead array assay for IL-6 17 of 44
samples were not detectable (≤ 8pg/mL), whereas for TNF-
α 20 of 44 samples were not detectable (≤ 36pg/mL). In the
IL-6 ELISA only one sample was below the detection level.
Correlationsofmultiplex-25measuredcytokines
The cytokines IL-6, IL-8, IL10, IL-12, TNF-α,M I P - 1 β,
and MCP-1 were signiﬁcantly correlated with each other
(Table 4), whereas IL-12p40 was only (highly) correlated
with IL-1RA (Figure 2).
DISCUSSION
Thisstudyinvestigatedtheinvolvementofinﬂammatoryme-
diators in CRPS1 represented by a large variety of cytokines
simultaneously measured in one small blister ﬂuid sample.
Use of the new multiplex-25 bead array assay allowed to de-
termine 10 cytokines in blister ﬂuid samples, considerably
above the relatively high detection levels of these integrated
cytokine assays.
Inﬂammatorypanel
In our earlier observations of mediators in blister ﬂuid of
CRPS1 patients (reﬂecting inﬂammation at the aﬀected ex-
tremity), we decided to measure both IL-6 and TNF-α as
representative markers of inﬂammation [9, 10, 19]. At that
time the amounts of cytokines we found were within the
ranges reported for other (mainly dermatological) diseases
(Table 1). The present results obtained after simultaneous
measurement of cytokines by the multiplex-25 array assay
were (although 2-3 times higher) in the same range. In those
44blisterﬂuidsampleshighcorrelationswerefoundbetween
data obtained from ELISA measurements and the multiplex-
25 bead array assays (Figures 1(a) and 1(b)).
In addition to these ﬁndings, signiﬁcant amounts of
other (pro-) inﬂammatory cytokines were detectable in blis-
ter ﬂuid by the multiplex-25 bead array assay, namely, IL-8
and IL-12p40/p70. Furthermore, relatively high amounts of
IL-1RA were found. Amounts of IL-1RA were comparable to
those found by Blaha et al [20].
Using the multiplex-25 bead array assay, GM-CSF was
notdetectable.Thiswas,however,alsothecaseinblisterﬂuidClaudia Heijmans-Antonissen et al 5
Table 1: Literature overview of cytokine levels in blister ﬂuid measured by ELISA. Data are medians or otherwise means (indicated by m).
ND: not determined.
Disease Refs Extremity IL-1β IL-6 IL-8 TNF-α IL-4 IL-10
(pg/mL) (pg/mL) (pg/mL) (pg/mL) (pg/mL) (pg/mL)
Complex regional
pain syndrome 9,10 involved ≤ 25 4 — 3 1 — —
noninvolved ≤ 26 — 8——
Psoriasis 33,34 involved 122 1683 — 145 — —
noninvolved ≤ 3 121 — 9 — —
Psoriasis 35 involved — 870 — 195 — —
noninvolved — 423 — 84 — —
Epidermal 36 involved — 66 10 — — 33
necrolysis noninvolved — ND ND — — ND
Bullous 21,37 involved 73m 245m —— 95 4
pemphigus noninvolved 2m 16m —— ≤ 4 ≤ 5
Bullous 38 i n v o l v e d —————7 3
pemphigus noninvolved — — — — — ND
Pemphigus 39 i n v o l v e d ————— 1 8 6 m
vulgaris noninvolved — — — — — ND
Table 2: Cytokine levels in blister ﬂuids from 22 patients with complex regional pain syndrome measured by ELISA. Blister ﬂuids were
diluted 4-fold in matrix buﬀer. Lowest detectable level: lowest detectable standard which signiﬁcantly diﬀers from zero standard (experi-
mentally determined).
ELISA
lowest detectable
level (pg/mL)
levels in blister ﬂuid median (range) in pg/mL
noninvolved CRPS1 P-value
Inﬂammatory panel
IL-6 0.22 .7( ≤ 0.8–191) 38 (≤ 0.8–346) 0.002
TNF-α 0.51 0 .3( 2 .1–315) 48 (2.8–381) 0.006
of patients with bullous pemphigus (BP), a chronic auto-
immune blistering disease, in which GM-CSF was not de-
tectable (< 5pg/mL) by ELISA [21].
Th1/Th2panel
In the present study we concluded that the cytokines IFN-
γ, IL-2, IL-2R, IL-4, IL-5, and IL-10 normally involved in
the Th1/Th2 pathways were negligible, because all calcu-
lated data were around or beneath the detection limits of the
multiplex-25 bead array assay.
Detectable amounts of IL-4 and IL-10 (Table 1)a n do f
soluble IL-2R have been measured in the blister ﬂuid of pa-
tients with toxic epidermal necrolysis, a disease in which the
early participation of activated CD8+ Tl y m p h o c y t e sp l a ya n
important role [22].
Chemokines
Eotaxin and IL-5 are representative chemotactic cytokines
to study the activation of skin-homed eosinophils, which
in general represent allergic reactions [23]. In pemphigoid
gestationis, a rare autoimmune bullous disease of late preg-
nancy, both markers are signiﬁcantly increased in blister
ﬂuid [24]. In another study, elevated levels of both eotaxin
and IL-5 in blister ﬂuid of BP were found, suggesting tissue
eosinophilia [25].
In the present study IL-5 was not detectable, although
low detection ranges were achieved. On the contrary, eotaxin
was detectable at levels > 12pg/mL blister ﬂuid, but was sur-
prisinglydecreasedinCRPS1blisterﬂuid.Therefore,wecon-
cluded that allergic reactions do not play an important role
in CRPS1.
In our study, both MCP-1 and MIP-1β were present
in blister ﬂuid in signiﬁcant amounts and were increased
in CRPS1 blisters in comparison with noninvolved blister
samples, suggesting an ongoing involvement of activated
monocytes and macrophages. In blisters generated in skin
of chronic ambulatory peritoneal dialysis patients, however,
MCP-1 concentrations in this interstitial ﬂuid were not re-
lated to the intensity of the inﬂammation [26, 27].
Sourceofcytokines
The involvement, cellular sources and most prominent ef-
fects of cytokines in BP, partly detected in blister ﬂuids,
have been reviewed extensively [28, 29]. In our observations,6 Mediators of Inﬂammation
Table 3: Cytokine levels in blister ﬂuids from 22 patients with complex regional pain syndrome measured by multiplex-25 bead array assay.
Blister ﬂuids were diluted 4-fold in matrix buﬀer. Lowest detectable level: lowest detectable standard which signiﬁcantly diﬀers from zero
standard (experimentally determined). P-values: nt: not tested, because all measured outcomes were below detection level.
25-plex
lowest detectable
level (pg/mL)
levels in blister ﬂuid median (range) in pg/mL
noninvolved CRPS1 P-value
Inﬂammatory panel
GM-CSF 11 all ≤ 44 all ≤ 44 nt
IL-1β 12 all ≤ 48 all ≤ 48 nt
IL-1RA 50 35940 48894 < .001
(12665–67549) (23393–90714)
IL-6 2 ≤ 8( ≤ 8–100) 100 (≤ 8–2055) .001
IL-8 7 ≤ 28 (≤ 28–301) 46 (≤ 28–519) .006
TNF-α 9 ≤ 36 (≤ 36–829) 195 (≤ 36–1923) .013
Th1/Th2 panel
IFN-γ 3a l l ≤ 12 all ≤ 12 nt
IL-2 4 all < 16 all ≤ 16 nt
IL-2R 30 all ≤ 120 all ≤ 120 nt
IL-4 2 all ≤ 8a l l ≤ 8n t
IL-5 2 all ≤ 8a l l ≤ 8n t
IL-10 4 20 (≤ 16–51) 21 (≤ 16–50) .336
Cytokine II panel
IFN-α 10 all ≤ 40 all ≤ 40 nt
IL-7 28 all ≤ 112 all ≤ 112 nt
IL-12p40 4 325 (192–540) 386 (256–542) .007
IL-13 3 all ≤ 12 all ≤ 12 nt
IL-15 6 all ≤ 24 all ≤ 24 nt
IL-17 6 all ≤ 24 all ≤ 24 nt
Chemokine panel
Eotaxin 3 29 (15–54) 24 (≤ 12–55) .009
IP-10 3 48 (24–185) 37 (≤ 12–137) .025
MCP-1 3 297 (126–1570) 579 (188–4415) .002
MIP-1α 10 all ≤ 40 all ≤ 40 nt
MIP-1β 10 199 (116–450) 290 (135–557) .001
MIG 12 all ≤ 48 all ≤ 48 nt
RANTES 10 all ≤ 40 all ≤ 40 nt
a number of detectable mediators measured at the CRPS1
side were correlated individually, except for IL-1RA, eotaxin,
and IP-10 (Table 4). Our data suggest that detectable me-
diators have been generated by a homogenous cell popula-
tion. Because T-cells apparently are not involved, the most
likely candidates are monocytes, macrophages, and possibly
ﬁbroblasts. The main products generated by these cells are
IL-6, IL-8, IL-10, IL-12, and TNF-α. Apparently, skin mast
cells are also involved, as reﬂected by increased amounts of
tryptase in CRPS1 blister ﬂuid [10]. The main cytokine pro-
duced by mast cells is TNF-α.
The amount of cytokines IL-8, IL-6, MCP-1, GM-CSF,
TNF-α,a n dM I P - 1 β secreted by human epithelial cells from
the female reproductive tract was recently assessed by Lu-
minex bead array analysis [30]. The main products found
wereIL-8andIL-6,butthesewere100-foldhigherthanthose
of GM-CSF, TNF-α,a n dM I P - 1 β. Therefore, regarding the
distribution of our data, it is unlikely that epithelial cells
contributed to the levels of cytokines found in blister ﬂuid
of CRPS1 patients.
Sensitivityofmultiplex-25beadarrayassay
The sensitivity of multiplex bead array assays for the detec-
tion of soluble cytokines and the quantitative values from
several manufacturers have been compared for serum sam-
ples [31]. Bead array and ELISA values appeared to be com-
parable between the manufacturers. The minimal detection
range for the Biosource kit was comparable with the R&D
Systems assay kit, but about 2-fold and 5-fold higher than
kits from Bio-Rad and LINCO Research, respectively. The
simultaneous measurement of 15 human cytokines (Bio-
Plex system from Bio-Rad) in a single sample of cultured
peripheral blood mononuclear cells compared with regular
ELISA kits (purchased from a number of manufacturers), re-
sulted in high correlation coeﬃcients ranging from 0.75 toClaudia Heijmans-Antonissen et al 7
Table 4: Nonparametric correlations of cytokines in blister ﬂuid
from CRPS1 hand. P-values: a <. 001, b <. 005, c <. 01, d <. 02,
e <. 05.
IL-8 IL-10 IL-12 TNF-α MIP-1β MCP-1
IL-1RA — — 0.94a ———
IL-6 0.85a 0.56c 0.51d 0.78a 0.72a 0.88a
IL-8 — 0.63b 0.44e 0.93a 0.76a 0.88a
IL-10 — — — 0.56c 0.62b 0.59b
IL-12 — — — 0.48e 0.50d 0.47e
TNF-α ——— — 0 .67b 0.81a
MIP-1 — — — — — 0.68e
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Figure 2: Example of a regression curve between concentrations of
IL-1RA and IL-12 in 22 blister ﬂuid samples taken from the CRPS1
extremity (correlation coeﬃcient 0.97, P<. 001), measured by the
multiplex-25 bead array assay. Values are calculated in pg/mL and
plotted on a logarithmic scale.
0.99 [32]. Our comparison between the multiplex-25 bead
arrayassayandELISAsforIL-6andTNF-αalsorevealedhigh
correlation coeﬃcients, ranging from 0.85 to 0.88 (Figure 1).
The high detection levels in the present study were partly
caused by the 4-fold dilutions needed to enable separate de-
terminations by ELISA techniques. Generally, at least 50μL
will be recovered per blister evoked by suction. After a 2-fold
dilution in assay matrix buﬀer a duplicate measurement by
the multiplex bead array assay could be performed. Then de-
tection levels will be more acceptable; however, they will still
be 3-fold (or even more) increased compared with the com-
monly used ELISAs. In case of paired sample measurements
(involved versus noninvolved) or treatment-aﬀected paired
sample measurements, these shortcomings are acceptable for
the selectedcytokine panels asdemonstrated by theresultsof
this study.
We failed to detect substantial amounts of protein in
blister ﬂuid of at least 15 selected cytokines assayed in this
multiplex-25 array system, although the detection of some of
these cytokines (such as IL-1β, IL-2, IL-5, IL-7, IL-15, IFN-γ,
and RANTES) has been realized in blister ﬂuid using com-
monly available ELISA kits which are more sensitive [28].
Based on these ELISA derived data, the levels of cytokines
detectable in blister ﬂuids taken from a variety of diseases
generallywereaboveourdetectionlimits.Therefore,wecon-
cluded that these cytokines are not prominent mediators in-
volved in CRPS1.
CONCLUSION
Based on our ﬁndings, routine application of a multiplex-
25 bead array assay to detect representative cytokines in blis-
ter ﬂuids would not be advisable. The use of this system is
advisable for investigational purposes or for diagnosis based
on selected cytokines from relevant literature. We therefore
propose that a selection of two or three representatives from
each panel (the inﬂammatory cytokines panel, the Th1/Th2
cytokines panel, and the chemokines panel) would be suﬃ-
cienttoindicatetheactivityoftheCRPS1disease.Duringthe
course of the disease this selected panel could also be used to
indicate the eﬀectiveness of therapeutic intervention. Based
on our data and the selection made by Fahey et al [30], we
suggest to include at least IL-6, IL-8, TNF-α,M C P - 1 ,M I P -
1β, IL-10, and IL-12 in that investigation panel.
Future research using blister ﬂuid should also focus on
standardization of the blister techniques and the warranted
inclusion of control samples, either from noninvolved tissue
or from healthy volunteers.
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